AVNS (Avanos Medical, Inc.) Stock Analysis - AI Report

Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on AVNS?

Rallies AI research for AVNS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

AVNS Key Metrics

Key financial metrics for AVNS
MetricValue
Price$24.74
Market Cap$1.16B
P/E Ratio-2.90
EPS$-8.53
Dividend Yield0.00%
52-Week High$24.91
52-Week Low$9.30
Volume0
Avg Volume0
Revenue (TTM)$687.80M
Net Income$-392.10M
Gross Margin55.44%

Latest AVNS News

Recent AVNS Insider Trades

  • Holbrook Kerr sold 13.83K (~$152.17K) on Nov 18, 2025.
  • Holbrook Kerr sold 100 (~$1.10K) on Nov 18, 2025.
  • Holbrook Kerr sold 761 (~$8.38K) on Nov 18, 2025.

AVNS Analyst Consensus

AVNS analyst coverage data. Average price target: $0.00.

Common questions about AVNS

What is the AI research view on AVNS?
Rallies AI research for AVNS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for AVNS?
Rallies AI research for AVNS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is AVNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.
AVNS

AVNS